Last update: July 1, 2015
Not risky for breastfeeding or infant.
Excreted into breast milk in non-significant amount with no problems among breastfed infants whose mothers were treated with this medication. No alteration on breast milk composition has been seen.
Shown to be effective at a dose of 10 - 20 mg three times-a-day for pain relief related to Raynaud's phenomena of the nipple, which is a highly painful vasospasm triggered by cold exposition or trauma produced by inadequate latch-on to the breast. Side effect on the mother should be addressed.
American Academy of Pediatrics 2001: Maternal Medication Usually Compatible With Breastfeeding.
Eleventh WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.
We do not have alternatives for ニフェジピン since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM